Criteria Venture Tech

Mobile Media Content, a Barcelona, Spain-based provider of virtual visualization technologies, raised €400k in seed funding. Founded in May 2012 by Michele Marino, CEO and Francis Casado, Head of Business Development, Mobile Media Content provides TICKETING3D, a SaaS 3D seating chart of a venue, which allows the final user to check the view from his seat before purchasing a ticket. It also Tranfer3D, which lets any club or sports organization to move supporters or fans from one location to another, and Match3D, a 2nd screening tool that allows following matches in real time. The company currently employs 20 people

Amelia Virtual Care is a mental health technology company with offices in Barcelona and Mountain View, specializing in a comprehensive virtual reality platform designed for mental health treatment. This platform enables professionals to address a variety of mental health disorders, including phobias, anxiety, and depression. With a workforce of over 60 employees, Amelia has successfully delivered more than 200,000 VR therapy sessions, primarily in the United States, which serves as its main market. The company's innovative platform includes multiple features and user-friendly controls, facilitating effective therapy sessions. Recent financing and a new management team are expected to enhance Amelia's growth and strengthen its clinical evidence and commercial activities.

Immfly is a leading provider of in-flight entertainment and connected digital services, headquartered in Barcelona, Spain, with a presence in various global markets. The company specializes in enhancing the onboard travel experience by allowing passengers to access a diverse range of premium entertainment content through their personal devices and aircraft screens. Immfly's platform includes video streaming, innovative channels, and efficient service delivery, all designed to optimize streaming speeds. This approach not only improves passenger satisfaction but also helps airlines reduce operational costs and create additional revenue streams. Immfly's services are utilized by full-service, low-cost, and regional airlines, reaching millions of travelers across hundreds of destinations worldwide.

Immfly is a leading provider of in-flight entertainment and connected digital services, headquartered in Barcelona, Spain, with a presence in various global markets. The company specializes in enhancing the onboard travel experience by allowing passengers to access a diverse range of premium entertainment content through their personal devices and aircraft screens. Immfly's platform includes video streaming, innovative channels, and efficient service delivery, all designed to optimize streaming speeds. This approach not only improves passenger satisfaction but also helps airlines reduce operational costs and create additional revenue streams. Immfly's services are utilized by full-service, low-cost, and regional airlines, reaching millions of travelers across hundreds of destinations worldwide.

Validated ID is a technology company based in Barcelona, Spain, founded in 2012, that specializes in biometric signature solutions. The company offers ViDsigner, a mobile biometric signature system that enables users to securely send documents for signing while collecting biometric and contextual evidence to ensure legal validity. In addition to ViDsigner, Validated ID provides ViDChain, a decentralized identity solution based on blockchain technology that focuses on onboarding and Know Your Customer (KYC) processes. The company's services cater to various sectors, including social work, healthcare, public administration, human resources, banking, insurance, and sales. Validated ID promotes security, trust, efficiency, and legal compliance in digital identity verification and agreements. They have established strategic partnerships with organizations such as Microsoft and Samsung, enhancing their technological capabilities and market reach.

Amelia Virtual Care is a mental health technology company with offices in Barcelona and Mountain View, specializing in a comprehensive virtual reality platform designed for mental health treatment. This platform enables professionals to address a variety of mental health disorders, including phobias, anxiety, and depression. With a workforce of over 60 employees, Amelia has successfully delivered more than 200,000 VR therapy sessions, primarily in the United States, which serves as its main market. The company's innovative platform includes multiple features and user-friendly controls, facilitating effective therapy sessions. Recent financing and a new management team are expected to enhance Amelia's growth and strengthen its clinical evidence and commercial activities.

BYHOURS is an innovative platform that enables users to book hotel stays for short durations of 3, 6, or 24 hours at over 4,500 hotels globally. Founded in Barcelona in March 2012, BYHOURS operates in more than 25 countries and has established itself as a pioneer in the "pay-per-use" hotel model. This approach allows guests to select their preferred check-in and check-out times, paying only for the hours they occupy the room. This flexibility not only caters to the needs of travelers seeking efficient and cost-effective accommodation options but also supports hotels in optimizing their resources and increasing revenue. In addition to its consumer services, BYHOURS has evolved into a travel-tech company, offering B2B and B2B2C solutions through partnerships with notable firms such as SABRE and RAPPI.

Amelia Virtual Care is a mental health technology company with offices in Barcelona and Mountain View, specializing in a comprehensive virtual reality platform designed for mental health treatment. This platform enables professionals to address a variety of mental health disorders, including phobias, anxiety, and depression. With a workforce of over 60 employees, Amelia has successfully delivered more than 200,000 VR therapy sessions, primarily in the United States, which serves as its main market. The company's innovative platform includes multiple features and user-friendly controls, facilitating effective therapy sessions. Recent financing and a new management team are expected to enhance Amelia's growth and strengthen its clinical evidence and commercial activities.

Splice Bio is a biotechnology company based in Barcelona, Spain, focused on developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012 and originally named Proteodesign, S.L., the company aims to address the needs of patients suffering from incurable genetic diseases. The intein platform, developed from research in the Muir Lab at Princeton University, seeks to overcome two significant limitations of traditional adeno-associated virus (AAV) therapies: it enhances the capacity for larger gene delivery and broadens the range of tissues that can be targeted for treatment.

ABAC Therapeutics S.A., based in Barcelona, Spain, specializes in the development of precision antimicrobial agents aimed at treating multidrug-resistant (MDR) Gram-negative infections. Established in 2014, the company utilizes its innovative PasNas drug discovery platform to identify pathogen-specific antibacterial properties of various molecules. This platform not only focuses on potent antibacterial activity but also emphasizes the importance of favorable pharmacokinetics and toxicological profiles to enhance the likelihood of success in clinical development. ABAC Therapeutics seeks to provide first-in-class therapeutic alternatives for patients suffering from infections caused by antibiotic-resistant bacterial pathogens, particularly targeting the significant challenge posed by the major MDR Gram-negative bacteria. As of November 2019, the company operates as a subsidiary of Tibidabo Ventures.

Vilynx, Inc. is a technology company that offers an online platform for managing video content, enhancing viewer engagement, and providing detailed analytics. Founded in 2011 and based in Palo Alto, California, with an additional office in Barcelona, Spain, Vilynx enables users to publish, edit, store, share, and browse videos effectively. The platform allows users to create engaging summaries, add rich metadata for improved search capabilities, and generate interactive video clips that attract audience attention. Utilizing machine learning technology, Vilynx enhances video personalization and helps publishers increase viewer engagement, with metrics showing significant improvements in video views and viewing time. The platform also provides comprehensive data analytics, offering insights into viewer behavior and content performance. Through its APIs, clients can access dashboards that reveal which parts of their videos are most engaging, ultimately aiming to maximize audience interaction and boost advertising revenue.

Transplant Biomedicals S.L., founded in 2014 and based in Barcelona, Spain, specializes in the design and development of medical devices focused on organ, tissue, and cellular preservation. The company aims to enhance patient wellness by leveraging proprietary technology that improves graft survival and reduces the risk of delayed graft function. Their innovative organ transport device facilitates the safe and effective transfer of organs and tissues from donor hospitals to transport centers, addressing the issue of marginal organs that are often discarded. Through its advancements, Transplant Biomedicals contributes to more efficient organ transplantation processes and better outcomes for patients.

Worldcoo is a Barcelona-based social company focused on funding NGO projects through partnerships with e-commerce platforms, banks, and retailers. Founded in 2012, the company offers a unique fundraising mechanism called Charity Rounding Up, which allows customers to round up their purchase totals and donate the spare change to social causes whenever they use their cards. Worldcoo emphasizes innovation, solidarity, and transparency in its operations and is recognized as part of the B Corp movement. The company has received support from the European Commission through its participation in the Horizon2020 project, highlighting its commitment to social impact. By enabling various organizations, including NGOs and government entities, to implement transformative projects, Worldcoo aims to improve the lives of those in need and contribute to a better world.

BANDIT Solutions, S.L. operates an online recruitment platform based in Barcelona, Spain, established in 2011. The platform, launched in December 2016, focuses on connecting companies with top digital talent actively seeking new job opportunities. By utilizing data mining and machine learning tools, BANDIT streamlines the hiring process, enabling businesses to pre-select candidates based on specific project requirements. This innovative approach places talent at the forefront of the recruitment process, facilitating efficient matches between job seekers and employers. The leadership team includes Francesc Font and twins Jorge and Nicolás Araujo, along with Sergio Méndez.

Nautal is an online boat rental platform that enables direct contact with the owners. It also offers rental of motorboats, catamarans, pontoons, sailboats, yacht, and etc. Nautal operates in more than 350 areas in 56 countries around the world. It was founded in 2013 and is headquartered in Barcelona, Spain.

Datumize, established in 2014 and headquartered in Castelldefels, Barcelona, specializes in enterprise data integration software. It captures and transforms 'dark data'—hidden, untapped data within organizations—into actionable insights. By doing so, Datumize helps businesses in sectors like logistics, retail, and industry make informed decisions, enhance operational efficiencies, and ultimately boost revenues. The company was acquired in 2023.

Forever Us is a technology company based in Barcelona, Spain, that specializes in the design and manufacture of funeral art, including headstones, tombs, crypts, and urns. The company collaborates with chapels of rest, funeral directors, and insurance providers to create customizable headstones made from ecological materials. These gravestones can be tailored with various backgrounds, landscapes, spiritual motifs, poems, dedications, and typographies, allowing families to memorialize their loved ones in a personal and lasting manner. Established in 2012, Forever Us also commits 1% of its profits to support social projects and assist in mitigating the impacts of natural disasters.

CornerJob is a Barcelona-based startup, part of the Southern Europe's leading digital ecosystem, which aims to streamline job recruitment. It offers a mobile platform enabling users to find geolocated job offers, apply directly, chat with recruiters, and receive responses within 24 hours. For businesses, CornerJob provides a simple, interactive, and immediate recruiting channel, aiding in the selection process by minimizing timeouts through its chat feature.

Immfly is a leading provider of in-flight entertainment and connected digital services, headquartered in Barcelona, Spain, with a presence in various global markets. The company specializes in enhancing the onboard travel experience by allowing passengers to access a diverse range of premium entertainment content through their personal devices and aircraft screens. Immfly's platform includes video streaming, innovative channels, and efficient service delivery, all designed to optimize streaming speeds. This approach not only improves passenger satisfaction but also helps airlines reduce operational costs and create additional revenue streams. Immfly's services are utilized by full-service, low-cost, and regional airlines, reaching millions of travelers across hundreds of destinations worldwide.

Genmedica Therapeutics, S.L. is a clinical-stage biopharmaceutical company based in Barcelona, Spain, specializing in the research and development of innovative treatments for type 2 diabetes. Founded in 2004, the company is focused on creating orally available new chemical entities (NCEs), including its lead compounds, GMC-252 and GMC-316, which aim to effectively lower glycemia while also modifying the disease's progression. Additionally, Genmedica is advancing the GMC-278 drug discovery program to identify new molecules that target both type 2 diabetes and obesity. By leveraging its proprietary OSIF platform, the company seeks to develop dual-action small molecules that address oxidative stress and inflammation, ultimately improving the quality of life for diabetic patients.

Transplant Biomedicals S.L., founded in 2014 and based in Barcelona, Spain, specializes in the design and development of medical devices focused on organ, tissue, and cellular preservation. The company aims to enhance patient wellness by leveraging proprietary technology that improves graft survival and reduces the risk of delayed graft function. Their innovative organ transport device facilitates the safe and effective transfer of organs and tissues from donor hospitals to transport centers, addressing the issue of marginal organs that are often discarded. Through its advancements, Transplant Biomedicals contributes to more efficient organ transplantation processes and better outcomes for patients.

Mowoot is a company that specializes in developing non-pharmacological and non-invasive solutions for individuals suffering from chronic constipation. It offers a wearable medical device that delivers an automatic, colon-specific massage, mimicking the manual abdominal massage typically performed by healthcare professionals. Utilizing advanced pneumatic technology, Mowoot's device aims to treat and prevent chronic slow transit constipation without the need for colon cleansing supplements, enemas, or laxatives. Founded in 2014 and based in Barcelona, Spain, Mowoot emerged from the MOEBIO dHEALTH program, which draws inspiration from innovative design and business methodologies. The company's mission is to enhance the quality of life for those affected by chronic constipation through its unique and effective approach.

Bibulu is an online platform designed to connect pet owners with suitable caregivers for their pets. Founded in February 2013 by Enrico Sargiacomo and Tomasz Matuszczyk, the company is headquartered in Barcelona, Spain. The platform facilitates communication between pet owners and dog hosts, allowing them to arrange dog boarding services in a home environment. By providing a user-friendly interface, Bibulu aims to simplify the process of finding reliable pet sitters, ensuring that pet owners can secure trustworthy care for their animals while they are away.

Nautal is an online boat rental platform that enables direct contact with the owners. It also offers rental of motorboats, catamarans, pontoons, sailboats, yacht, and etc. Nautal operates in more than 350 areas in 56 countries around the world. It was founded in 2013 and is headquartered in Barcelona, Spain.

nLife Therapeutics S.L. is a biopharmaceutical company based in Granada, Spain, with an additional office in Barcelona. Founded in 2009, the company specializes in developing innovative treatments for central nervous system (CNS) and neuromuscular disorders through the use of cell-specific oligonucleotides. nLife Therapeutics is focused on creating a first-in-class disease-modifying therapy aimed at selectively silencing alpha-synuclein in monoaminergic neurons to address the toxic accumulation associated with Parkinson’s disease. Additionally, the company is working on therapies to treat Huntington's Disease by lowering levels of altered Htt in striatal and cortical neurons to hinder disease progression. Their technology platform enables the targeted delivery of conjugated nucleic acids to specific neurons via a single intra-nasal application, with ongoing efforts to advance clinical trials for these promising treatments.

Mobile Media Content, a Barcelona, Spain-based provider of virtual visualization technologies, raised €400k in seed funding. Founded in May 2012 by Michele Marino, CEO and Francis Casado, Head of Business Development, Mobile Media Content provides TICKETING3D, a SaaS 3D seating chart of a venue, which allows the final user to check the view from his seat before purchasing a ticket. It also Tranfer3D, which lets any club or sports organization to move supporters or fans from one location to another, and Match3D, a 2nd screening tool that allows following matches in real time. The company currently employs 20 people

Vilynx, Inc. is a technology company that offers an online platform for managing video content, enhancing viewer engagement, and providing detailed analytics. Founded in 2011 and based in Palo Alto, California, with an additional office in Barcelona, Spain, Vilynx enables users to publish, edit, store, share, and browse videos effectively. The platform allows users to create engaging summaries, add rich metadata for improved search capabilities, and generate interactive video clips that attract audience attention. Utilizing machine learning technology, Vilynx enhances video personalization and helps publishers increase viewer engagement, with metrics showing significant improvements in video views and viewing time. The platform also provides comprehensive data analytics, offering insights into viewer behavior and content performance. Through its APIs, clients can access dashboards that reveal which parts of their videos are most engaging, ultimately aiming to maximize audience interaction and boost advertising revenue.

Genmedica Therapeutics, S.L. is a clinical-stage biopharmaceutical company based in Barcelona, Spain, specializing in the research and development of innovative treatments for type 2 diabetes. Founded in 2004, the company is focused on creating orally available new chemical entities (NCEs), including its lead compounds, GMC-252 and GMC-316, which aim to effectively lower glycemia while also modifying the disease's progression. Additionally, Genmedica is advancing the GMC-278 drug discovery program to identify new molecules that target both type 2 diabetes and obesity. By leveraging its proprietary OSIF platform, the company seeks to develop dual-action small molecules that address oxidative stress and inflammation, ultimately improving the quality of life for diabetic patients.

Wallapop is a Barcelona-based company, established in 2013, that operates a mobile-first marketplace for buying and selling secondhand goods. With over 15 million users, the platform connects locals via a user-friendly app, facilitating transactions of more than 180 million items. Wallapop's geo-localized technology enables users to find unique, pre-owned products at affordable prices, promoting sustainability by extending the life of functional items. The company, backed by prominent investors, aims to innovate in the online classifieds industry and contribute to a circular economy.

BYHOURS is an innovative platform that enables users to book hotel stays for short durations of 3, 6, or 24 hours at over 4,500 hotels globally. Founded in Barcelona in March 2012, BYHOURS operates in more than 25 countries and has established itself as a pioneer in the "pay-per-use" hotel model. This approach allows guests to select their preferred check-in and check-out times, paying only for the hours they occupy the room. This flexibility not only caters to the needs of travelers seeking efficient and cost-effective accommodation options but also supports hotels in optimizing their resources and increasing revenue. In addition to its consumer services, BYHOURS has evolved into a travel-tech company, offering B2B and B2B2C solutions through partnerships with notable firms such as SABRE and RAPPI.

Bibulu is an online platform designed to connect pet owners with suitable caregivers for their pets. Founded in February 2013 by Enrico Sargiacomo and Tomasz Matuszczyk, the company is headquartered in Barcelona, Spain. The platform facilitates communication between pet owners and dog hosts, allowing them to arrange dog boarding services in a home environment. By providing a user-friendly interface, Bibulu aims to simplify the process of finding reliable pet sitters, ensuring that pet owners can secure trustworthy care for their animals while they are away.

The eTailers, a Barcelona, Spain-based e-commerce outsourcing company. Their mission is to invent, create, develop and consolidate innovative companies and global, offering products or services related always new technologies, especially the Internet. They have innovative entrepreneurial spirit and work closely with the university, with the aim of promoting excellence in knowledge and innovation in all projects we undertake.

nLife Therapeutics S.L. is a biopharmaceutical company based in Granada, Spain, with an additional office in Barcelona. Founded in 2009, the company specializes in developing innovative treatments for central nervous system (CNS) and neuromuscular disorders through the use of cell-specific oligonucleotides. nLife Therapeutics is focused on creating a first-in-class disease-modifying therapy aimed at selectively silencing alpha-synuclein in monoaminergic neurons to address the toxic accumulation associated with Parkinson’s disease. Additionally, the company is working on therapies to treat Huntington's Disease by lowering levels of altered Htt in striatal and cortical neurons to hinder disease progression. Their technology platform enables the targeted delivery of conjugated nucleic acids to specific neurons via a single intra-nasal application, with ongoing efforts to advance clinical trials for these promising treatments.

Genmedica Therapeutics, S.L. is a clinical-stage biopharmaceutical company based in Barcelona, Spain, specializing in the research and development of innovative treatments for type 2 diabetes. Founded in 2004, the company is focused on creating orally available new chemical entities (NCEs), including its lead compounds, GMC-252 and GMC-316, which aim to effectively lower glycemia while also modifying the disease's progression. Additionally, Genmedica is advancing the GMC-278 drug discovery program to identify new molecules that target both type 2 diabetes and obesity. By leveraging its proprietary OSIF platform, the company seeks to develop dual-action small molecules that address oxidative stress and inflammation, ultimately improving the quality of life for diabetic patients.

Sagetis Biotech, S.L., founded in 2010 and based in Barcelona, Spain, is a biotechnology company focused on developing innovative polymeric technologies for gene therapy. The company addresses engineering challenges in drug delivery, specifically for diseases of the central nervous system. Sagetis Biotech has created polymer-coated adenovirus release systems that enhance drug administration efficacy, particularly against pre-existing neutralizing antibodies. One of its notable products is SAG-101, designed for treating pancreatic ductal adenocarcinoma. By masking surface antigenic epitopes, these systems preserve the transduction capability of oncolytic viruses, thereby improving their therapeutic effects and enabling healthcare professionals to more effectively modify treatment outcomes.

InAtlas is an information technology and consultancy company based in Barcelona, Spain, founded in January 2010. It specializes in providing online strategic business solutions focused on location analytics and competitive intelligence. The company's primary offering is a self-service application that enables users to optimize business decision-making by analyzing the locations of clients, competitors, and suppliers. This application aids businesses in planning, designing marketing campaigns, identifying new customers, implementing geo-marketing strategies, and selecting ideal locations for franchises. InAtlas's services also encompass competitor monitoring, real estate analysis, and the identification of economic patterns, empowering clients to make informed and effective business decisions.

Sagetis Biotech, S.L., founded in 2010 and based in Barcelona, Spain, is a biotechnology company focused on developing innovative polymeric technologies for gene therapy. The company addresses engineering challenges in drug delivery, specifically for diseases of the central nervous system. Sagetis Biotech has created polymer-coated adenovirus release systems that enhance drug administration efficacy, particularly against pre-existing neutralizing antibodies. One of its notable products is SAG-101, designed for treating pancreatic ductal adenocarcinoma. By masking surface antigenic epitopes, these systems preserve the transduction capability of oncolytic viruses, thereby improving their therapeutic effects and enabling healthcare professionals to more effectively modify treatment outcomes.

SabirMedical S.L. is a biomedical research and development company based in Barcelona, Spain, founded in 2007. The company specializes in developing innovative technologies for diagnostics and patient care, particularly in the area of cardiovascular monitoring. Its offerings include non-invasive blood pressure monitoring systems that utilize pulse oximetry, designed for hospital, ambulatory, and home use. SabirMedical operates from the Bioincubator PCB-Santander space at Barcelona Science Park, emphasizing its commitment to advancing healthcare through technology.

EscapadaRural, Servicios para propietarios S.L., established in 2007 and headquartered in Barcelona, Spain, operates an online platform dedicated to rural vacation rentals. The platform serves as a resource for travelers seeking to discover and book accommodations in rural areas, facilitating access to a variety of rural houses. It also provides a reservation management application for property owners, enabling them to efficiently advertise their listings and promote their businesses. Through its services, EscapadaRural connects travelers with rural lodging options, supporting the growth of tourism in these communities.

Careesma is an online platform that publishes job listings from Europe and India. Employers post their vacancies in categories such as accounting, banking, HR, marketing, internships, administrative, sales, testing, education, health, and more. Individuals have access to tools that help them prepare cover letters and resumes as well as for job interviews and careers. Careesma was launched in 2004 and is operated from Barcelona, Spain.